Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying the side effects and how well giving tetradecanoylphorbol
acetate together with dexamethasone and choline magnesium trisalicylate works in treating
patients with relapsed or refractory acute myeloid leukemia.
Phase:
Phase 2
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborators:
Biosuccess Biotech Co., Ltd. National Cancer Institute (NCI) Rutgers Cancer Institute of New Jersey